Vascularization enhanced graft constructs

• US 7,795,022 B2
• Filed: 05/02/2003
• Issued: 09/14/2010
• Est. Priority Date: 05/02/2002
• Status: Active Grant

• Current Assignee: Purdue Research Foundation (The Trustees of Purdue University (d/b/a Purdue University))
• Original Assignee: Purdue Research Foundation (The Trustees of Purdue University (d/b/a Purdue University))
• Inventors: Badylak, Stephen F.
• Primary Examiner(s): Davis; Ruth A
• Application Number:
  US10/428,355
• Publication Number:
  US 20030216812A1
• Time in Patent Office: 2,692 Days
• Field of Search: 424/400, 424/422, 424/572, 435/325, 435/371
• US Class Current: 435/371
• CPC Class Codes: A61K 35/34 Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes vascular smooth muscle A61K35/44
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/3808 Endothelial cells
• CPC Class Codes: A61L 27/3813 Epithelial cells, e.g. keratinocytes, urothelial cells
• CPC Class Codes: A61L 27/3826 Muscle cells, e.g. smooth muscle cells
• CPC Class Codes: A61L 27/383 Nerve cells, e.g. dendritic cells, Schwann cells
• CPC Class Codes: A61L 27/3886 comprising two or more cell types

Abstract

A tissue graft construct for use in repairing diseased or damaged tissues is provided. The tissue graft construct comprises a matrix composition selected from the group consisting of liver basement membrane and extracts and hydrolysates thereof, and processed collagen from vertebrate non-submucosal sources, added endothelial cells, and at least one additional preselected, exogenous population of cells which enhance the initiation of vessel-like structures in the grant. The preselected population of cells can be a population of non-keratinized or keratinized epithelial cells or a population of mesodermally derived cells selected from the group consisting of fibroblasts, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, multi-potential progenitor cells, pericytes, osteogenic cells, and any other suitable cell type, preferably selected based on the tissue to be repaired. Methods for enhancing the vascularization in vivo of these tissue graft constructs and for preparing these graft constructs are also provided.

Claims

1. A remodelable tissue graft construct having vessel-like structures for implantation into a host for use in repairing diseased or damaged tissues, said tissue graft construct comprising

(i) a matrix composition selected from the group consisting of liver basement membrane, extracts of liver basement membrane, and hydrolysates of liver basement membrane,

(ii) added endothelial cells,

(iii) at least one additional preselected, exogenous population of cells, and

(iv) vessel-like structures, wherein said additional population of cells enhances the initiation of formation of said vessel-like structures in said graft construct.

2. The graft construct of claim 1 wherein the at least one additional cell population comprises a population of cells selected from the group consisting of keratinized epithelial cells, non-keratinized epithelial cells, and mesodermally derived cells.

3. The graft construct of claim 1 wherein the at least one additional cell population comprises a population of smooth muscle cells.

4. The graft construct of claim 1 wherein the at least one additional cell population comprises a population of smooth muscle cell progenitor cells.

5. The graft construct of claim 1 wherein the at least one additional cell population comprises fibroblasts.

6. The graft construct of claim 1 further comprising a heparinase.

7. The graft construct of claim 1 further comprising a growth factor selected from the group consisting of vascular endothelial cell-derived growth factor, platelet-derived growth factor, a platelet-derived growth factor-like molecule, transforming growth factor β

, and a serum growth factor.

8. The graft construct of claim 1 wherein the matrix composition is seeded with the additional preselected population of cells after the matrix composition is seeded with the endothelial cells.

9. The graft construct of claim 1 wherein the matrix composition is seeded with the endothelial cells after the matrix composition is seeded with the additional preselected population of cells.

10. The graft construct of claim 1 wherein the matrix composition is seeded with the endothelial cells and the additional preselected population of cells simultaneously or nearly simultaneously.

12. The graft construct of any of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11, wherein said matrix composition comprises liver basement membrane.

11. A remodelable vascularized tissue graft construct for implantation into a host for use in repairing diseased or damaged tissues, said tissue graft construct comprising

(i) a matrix composition selected from the group consisting of liver basement membrane, extracts of liver basement membrane, and hydrolysates of liver basement membrane,

(ii) added endothelial cells,

(iii) at least one additional preselected, exogenous population of cells, and

(iv) vessel-like structures, wherein said additional population of cells enhances the initiation of vascularization of said graft construct.